Abstract
The basis of amnesia in alcoholic Wernicke-Korsakoff syndrome (WKS) has been generally associated with diencephalic lesions and more specifically with lesions of the anterior thalamic nuclei. These brain structures are considered to be involved in encoding/consolidation processes of episodic memory. However, frontal lobe damage responsible for executive function deficits has also been documented. The present report details the nature and extent of amnesia in an alcoholic patients with WKS and which appears to be mainly due to frontal lobe (executive) deficits.
References
1.
Korsakoff SS: Etude médico-psychologique sur une forme des maladies de la mémoire. Rev Philos 1889;24:501–530.
2.
Alexander L: Wernicke’s disease: Identity of lesions produced experimentally by B1 avitaminosis in pigeons with haemorrhagic polioencephalitis occurring in chronic alcoholism in man. Am J Pathol 1940;16:61–70.
3.
Darnton-Hill I, Truswell AS: Thiamin status of a sample of homeless clinic attenders in Sydney. Med J Aust 1990;152:5–9.
4.
Kopelman MD: The Korsakoff syndrome. Br J Psychiatry 1995;166:154–173.
5.
Harper CG: The incidence of Wernicke’s encephalopathy in Australia – A neuropathological study of 131 cases. J Neurol Neurosurg Psychiatry 1983;46:593–598.
6.
Mair WG, Warrington EK, Weiskrantz L: Locations of lesions in Korsakoff’s syndrome: Neuropsychological and neuropathological investigation of two cases. Brain 1979;102:749–783.
7.
Victor M, Amans RD, Collins GH: The Wernicke-Korsakoff Syndrome and Related Neurological Disorders Due to Alcoholism and Malnutrition. Philadelphia, Davis, 1989.
8.
Harding A, Halliday G, Caine D, Kril J: Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. Brain 2000;123:141–154.
9.
Joyce EM, Rio DE, Ruttimann UE: Decreased cingulated and precuneate glucose utilization in alcoholic Korsakoff’s syndrome. Psychiatry Res 1994;54:225–239.
10.
Kril J, Halliday GM, Svoboda MD, Cartwright H: The cerebral cortex is damaged in chronic alcoholics. Neuroscience 1997;79:983–998.
11.
Shimamura AP, Jernigan TL, Squire L: Korsakoff’s syndrome: Radiological (CT) findings and neuropsychological correlates. J Neurosci 1988;8:4400–4410.
12.
Fazio F, Perani D, Gilardi MC: Metabolic impairment in human amnesia: A PET study of memory networks. J Cereb Blood Flow Metab 1992;12:353–358.
13.
Arendt T, Bigl V, Arendt A: Loss of neurons in the nucleus basalis of Meynert in Alzheimer’s disease, paralysis agitans and Korsakoff’s disease. Acta Neuropathol 1983;61:101–108.
14.
Mayes AR, Meudell PR, Mann D: Location of lesions in Korsakoff’s syndrome: Neuropsychological and neuropathological data on two patients. Cortex 1988;24:367–388.
15.
Squire LR, Haist R, Shimamura AP: The neurology of memory: Quantitative assessment of retrograde amnesia in two types of amnesic patients. J Neurosci 1989;9:828–839.
16.
Butter N, Cermak LS: Alcoholic Korsakoff’s Syndrome: An Information-Processing Approach to Amnesia. New York, Academic Press, 1980.
17.
Kupfermann I: Learning and memory; in Kandel RR (ed): Principles of Neural Science. Connecticut, Appleton & Lange, 1991, pp 997–1008.
18.
Warrington E, Weiskrantz L: Amnesic syndrome: Consolidation or retrieval? Nature 1970;228:628–630.
19.
Baddeley AD: Working memory. Oxford, Oxford University Press, 1986.
20.
Kopelman MD: Two types of confabulation. J Neurol Neurosurg Psychiatry 1987;50:1482–1487.
21.
Stanhope N, Guinan E, Kopelman MD: Frequency judgments of abstract designs by patients with diencephalic, temporal lobe or frontal lobe lesions. Neuropsychologia 1998;36:1387–1396.
22.
Oscar-Berman M: Hypothesis testing and focusing behavior during concept formation by amnesic Korsakoff patients. Neuropsychologia 1973;11:191–198.
23.
Joyce EM, Robbins TW: Frontal lobe function in Korsakoff and non-Korsakoff alcoholics: Planning and spatial working memory. Neuropsychologia 1991;29:709–723.
24.
Jacobson RR, Acker CF, Lishman WA: Patterns of neuropsychological deficit in alcoholic Korsakoff’s syndrome. Psychol Med 1990;20:321–334.
25.
Pollux PMJ, Wester A, De Haan EHF: Random generation deficit in alcoholic Korsakoff patients. Neuropsychologia 1995;33:125–129.
26.
Harding A, Halliday G, Caine D, Kril J: Degeneration of anterior thalamic nuclei differentiates alcoholics with amnesia. Brain 2000;123:141–154.
27.
Visser PJ, Krabbendam L, Verhey FRJ, Hofman PAM, Verhoeven WMA, Tuinier S, Wester A, Van Den Berg YWMM, Goessens LFM, Van Der Werf YD, Jolles J: Brain correlates of memory dysfunction in alcoholic Korsakoff’s syndrome. J Neurol Neurosurg Psychiatry 1999;67:774–778.
28.
Kopelman MD: Frontal lobe dysfunction and memory deficits in the alcoholic Korsakoff syndrome and Alzheimer-type dementia. Brain 1991;114:117–137.
29.
Kopelman MD: The ‘new’ and the ‘old’: Components of the anterograde and retrograde memory loss in Korsakoff and Alzheimer patients; in Squire IR, Butters N (eds): The Neuropsychology of Memory. New York, Guilford, 1992, pp 130–146.
30.
Jacobson RR, Lishman W: Selective memory loss and global intellectual deficits in alcoholic Korsakoff’s syndrome. Psychol Med 1987;17:649–655.
31.
Welch LW, Nimmerrichter A, Kessler R, et al: Severe global amnesia presenting as Wernicke-Korsakoff syndrome but resulting from atypical lesions. Psychol Med 1996;26:421–425.
32.
Harper CG, Sheedy DL, Lara AI, Garrick TM, Hilton JM, Raisanen J: Prevalence of Wernicke-Korsakoff syndrome in Australia: Has thiamine fortification made a difference? Med J Aust 1998;168:542–545.
33.
Caine D, Halliday GM, Kril JJ, Harper CG: Operational criteria for the classification of chronic alcoholics: Identification of Wernicke’s encephalopathy. J Neurol Neurosurg Psychiatry 1997;62:51–60.
34.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental disorders. Washington, American Psychiatric Press, 1994.
35.
Harper C, Gold J, Rodriguez M, Perdices M: The prevalence of Wernicke-Korsakoff in Sydney, Australia: A prospective necropsy study. J Neurol Neurosurg Psychiatry 1989;52:282–285.
36.
Raven J: Guide to the Standard Progressive Matrices. London, Lewis, 1960.
37.
Brown J: Some tests of the decay theory of immediate memory. Q J Exp Psychol 1958;10:12–21.
38.
Peterson LR, Peterson MF: Short term retention of individual verbal items. J Exp Psychol 1959;58:193–198.
39.
Belleville S, Rouleau N, Caza N: Effect of normal aging on the manipulation of information in working memory. Mem Cognit 1998;26:572–583.
40.
Delis DC, Kramer JG, Kaplan E, Ober BA: The California Verbal Learning Test. New York, Psychological Corporation, 1987.
41.
Delis DC, Freeland J, Kramer JG, Kaplan E: Integrating clinical assessment with cognitive neuroscience. Construct validation of the California Verbal Learning Test. J Consult Clin Psychol 1988;46:123–130.
42.
Deweer B, Benoit N, Coyette F, Dubois B, Ergis AM, Eustache F, Hahn-Barma V, Hugonot L, Kalafat M, Le Roch K, Marié RM, Pasquier F, Pillon B, Poitrenaud J, Van der Linden M: Adaptation en langue française du California Verbal Learning Test. In preparation.
43.
Buschke H: Selective reminding for analysis of memory and learning. J Verbal Learn Verbal Behav 1973;12:543–550.
44.
Wickens D: Encoding categories of words: An empirical approach to memory. Psychol Rev 1970;77:1–15.
45.
Rey A: L’examen clinique en psychologie. Paris, Presses Universitaires de France, 1970.
46.
Grattan LM, Eslinger PF: Higher cognition and social behavior: Changes in cognitive flexibility and empathy alter cerebral lesions. Neuropsychology 1989;3:175–185.
47.
Eslinger PJ, Grattan LM: Frontal lobe and frontal-striatal substrates for different forms of human cognitive flexibility. Neuropsychologia 1993;31:17–28.
48.
Milner B: Some effects of frontal lobectomy in man; in Warren JM, Akert K (eds): Frontal Granular Cortex and Behavior. New York, McGraw-Hill, 1964, pp 313–331.
49.
Perret E: The left frontal lobe of man and the suppression of habitual responses in verbal categorical behaviour. Neuropsychologia 1974;20:29–262.
50.
Reitan RM: Validity of the Trail-Making Test as an indicator of organic brain damage. Percept Mot Skills 1958;8:271–276.
51.
Burgess PW, Shallice T: Response suppression, initiation and strategy use following frontal lobe lesions. Neuropsychologia 1996;34:263–273.
52.
Burgess PW, Shallice T: Bizarre responses, rule detection and frontal lobe lesions. Cortex 1996;32:241–259.
53.
Shallice T: Specific impairments of planning. Philos Trans R Soc Lond 1982;298:199–209.
54.
Brickenkamp R: Test d2: Aufmerksamkeits-Belastungs-Test (Handanweisung, 7th ed). Göttingen, Hogrefe, 1988.
55.
D’Esposito ME, Detre JA, Alsop DC, Shin RK, Atlas S, Grossman M: The neural basis of the central executive system of working memory. Nature 1995;378:279–281.
56.
Collette F, Salmon E, Van der Linden M, et al: Regional brain activity during tasks devoted to the central executive of working memory. Brain Res Cogn Brain Res 1999;7:411–417.
57.
Gershberg FB, Shimamura AP: Impaired use of organizational strategies in free recall following frontal lobe damage. Neuropsychologia 1995;13:1305–1333.
58.
Shallice T: From neuropsychology to mental structure. Cambridge, Cambridge University Press, 1988.
59.
Parkin AJ, Binschaedler C, Harsent L, Metzler C: Pathological false alarm rates following damage to the left frontal cortex. Brain Cogn 1996;5:326–343.
60.
Norman KA, Schacter DL: Implicit memory, explicit memory, and false recollection: A cognitive neuroscience perspective; in Reder LM (ed): Implicit Memory and Metacognition. Mahwah, Erlbaum, 1996, pp 229–257.
61.
Shimamura AP, Jurica PF, Mangels JA, Gershberg FB, Knight RT: Susceptibility to memory interference effects following frontal lobe damage: Findings from tests of paired-associate learning. J Cogn Neurosci 1995;7:144–153.
62.
Collette F, Van der Linden M, Delfiore G, Degueldre C, Salmon E: The functional anatomy of inhibition processes investigated with the Hayling task. J Neurol 1999;246:I/51.
63.
Tarter RE: An analysis of cognitive deficits in chronic alcoholics. J Nerv Ment Disord 1973,157:138–147.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
